What is DaNAcare?
DaNAcare is a NIPT test, meaning a non-invasive prenatal screening test. From a single blood sample taken from your arm, starting at week 10 of pregnancy, the lab analyses fragments of cell-free DNA that originate mainly in the placenta, to estimate the risk of certain chromosomal conditions in the fetus. The answer is given as low risk or increased risk. It is not a diagnosis.
What it screens for
- Trisomy 21 — Down syndrome
- Trisomy 18 — Edwards syndrome
- Trisomy 13 — Patau syndrome
- Selected sex chromosome conditions, depending on the type of pregnancy and the test level
- At the Advanced level: a genome-wide screen of all chromosomes, including partial deletions and duplications, subject to the laboratory's reporting threshold
Basic or Advanced, comparedAbout the test
What makes this test different here
The analysis is done in Israel
Your sample does not fly abroad. It goes to GGA laboratories, owned by Savyon Diagnostics, and the analysis is performed here.
Established technology
The test runs on Illumina's VeriSeq NIPT Solution v2, a whole-genome sequencing platform.
No doctor's referral needed
The test is private and you can book it directly. If you want to claim a refund from your supplementary health insurance you may need a document, and we will tell you exactly which one.
One person, start to finish
The same person explains the test, arranges the blood draw and calls you with the answer. Not a call centre, not an automated message.
Where you can take it
Blood is drawn at seven medical centres across Israel: Beer Sheva · Givatayim · Jerusalem · Haifa · Petah Tikva · Herzliya · Rishon LeZion. A home visit can also be arranged, subject to availability in your area. All appointments are booked in advance.
The centres and home visitsHow the test works
When
From week 10 of pregnancy. Before that, the share of pregnancy-derived DNA in the mother's blood is relatively low, which raises the chance that no result can be produced and a repeat sample is needed. No fasting and no preparation required.
Price and refundsQuestions and answers
Three things worth knowing first
This is a screening test, not a diagnosis
The answer tells you whether the risk is low or increased. An increased-risk result calls for genetic counselling and a diagnostic test such as amniocentesis before any decision is made.
It joins your pregnancy follow-up, it does not replace it
Nuchal translucency and anomaly scans remain part of your care. They detect things NIPT does not look at.
Twins, egg donation and surrogacy
In most cases the test can be done, but what can be reported differs from a singleton pregnancy. Tell us about your pregnancy and we will check together what your answer will include.
Talking to us
Our team speaks Hebrew and English. Call or leave your details and we will get back to you.
